According to Nurix Therapeutics's latest financial reports the company's current EPS (TTM) is -$2.75. In 2022 the company made an earnings per share (EPS) of -$3.73 a decrease over its 2021 EPS that were of -$2.73.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$2.75 | -26.27% |
2022 | -$3.73 | 36.63% |
2021 | -$2.73 | 24.3% |
2020 | -$2.20 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | -$2.18 | -20.73% | ๐บ๐ธ USA |